Table 2.

Association of ARVs with Fibrinogen

		% Effect* (95% CI)	P-value
Fibrinogen (Unadjusted Model)	Ritonavir	14.3 (10.0, 18.5)	<.0001
	Indinavir	15.7 (10.7, 21.3)	<.0001
	Efavirenz	−5.1 (−9.1, −0.8)	0.020
	Nevirapine	−12.8 (−17.7, −7.7)	<.0001
Fibrinogen (Adjusted Model 1)**	Ritonavir	12.3 (7.5, 17.2)	<.0001
	Indinavir	12.6 (7.1, 18.6)	<.0001
	Efavirenz	−4.4 (−8.9, 0.0)	0.049
	Nevirapine	−11.6 (−16.7, −6.7)	0.001
Fibrinogen (Adjusted Model 2)***	Ritonavir	11.4 (7.0, 15.6)	<.0001
	Indinavir	10.2 (5.5, 15.1)	<.0001
	Efavirenz	−5.9 (−9.8, −2.0)	0.002
	Nevirapine	−12.0 (−16.8, −7.2)	<.0001
	CRP (log 2)	7.2 (6.0, 8.3)	<.0001

^*Percent effect compares fibrinogen levels in ARV users to non-users for each ARV

^**Adjusted models also control for demographics, lifestyle factors, adipose tissue, HIV-related factors

^***Model 2 is further adjusted for CRP levels.